Molecular Partners AG (MOLN)
NASDAQ·Healthcare·Biotechnology
$4.28
-1.61%
Mkt Cap $183.26M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.38 | -$0.41 | -7.89% | — | — |
| Q4 2025 Oct 30, 2025 | — | — | — | -$0.46 | -$0.41 | +10.87% | — | — |
| Q3 2025 Aug 25, 2025 | — | — | — | -$0.53 | -$0.67 | -26.42% | — | — |
| Q2 2025 May 15, 2025 | — | — | — | -$0.42 | -$0.50 | -18.64% | — | — |
| Q1 2025 Mar 6, 2025 | — | — | — | -$0.44 | -$0.34 | +22.73% | — | — |
| Q4 2024 Oct 31, 2024 | $800.00K | $810.23K | +1.28% | -$0.63 | -$0.57 | +9.52% | — | — |
| Q3 2024 Aug 26, 2024 | $884.51K | $1.73M | +95.70% | -$1.26 | -$0.51 | +59.52% | — | — |
| Q2 2024 May 16, 2024 | $2.99M | $3.02M | +1.28% | — | -$0.39 | — | — | — |
| Q1 2024 Mar 14, 2024 | $1.75M | $1.21M | -31.08% | -$0.97 | -$0.68 | +29.90% | — | — |
| Q4 2023 Oct 26, 2023 | $1.52M | $2.77M | +81.91% | — | -$0.40 | — | — | — |
| Q3 2023 Aug 23, 2023 | $1.79M | $462.67K | -74.14% | — | -$0.55 | — | — | — |
| Q2 2023 May 12, 2023 | $1.80M | $3.33M | +84.88% | — | -$0.49 | — | — | — |
| Q1 2023 Mar 9, 2023 | $4.52M | $2.91M | -35.53% | $0.90 | -$0.56 | -162.22% | — | — |
| Q4 2022 Oct 27, 2022 | $3.32M | $2.37M | -28.52% | -$0.66 | -$0.42 | +35.97% | — | — |
| Q3 2022 Aug 25, 2022 | $12.24M | $12.26M | +0.20% | -$0.66 | -$0.15 | +77.13% | — | — |
| Q2 2022 May 12, 2022 | $178.91M | $186.63M | +4.32% | -$0.66 | $4.99 | +860.76% | — | — |
| Q1 2022 Mar 15, 2022 | $15.33M | $14.56M | -5.03% | -$1.04 | -$0.56 | +46.15% | — | — |
| Q4 2021 Oct 28, 2021 | — | $3.79M | — | — | -$0.41 | — | — | — |
| Q3 2021 Aug 26, 2021 | — | $3.48M | — | — | -$0.60 | — | — | — |
| Q2 2021 Jun 16, 2021 | — | $865.27K | — | — | -$0.60 | — | — | — |